APA (7th ed.) Citation

M, S., T, V., LY, L., SK, E., A, T., E, V., . . . R, E. (2024). Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: Analysis from the FNIH-ASBMR SABRE project. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 39(7), 867. https://doi.org/10.1093/jbmr/zjae068

Chicago Style (17th ed.) Citation

M, Schini, et al. "Pre-treatment Bone Mineral Density and the Benefit of Pharmacologic Treatment on Fracture Risk and BMD Change: Analysis from the FNIH-ASBMR SABRE Project." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 39, no. 7 (2024): 867. https://doi.org/10.1093/jbmr/zjae068.

MLA (9th ed.) Citation

M, Schini, et al. "Pre-treatment Bone Mineral Density and the Benefit of Pharmacologic Treatment on Fracture Risk and BMD Change: Analysis from the FNIH-ASBMR SABRE Project." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 39, no. 7, 2024, p. 867, https://doi.org/10.1093/jbmr/zjae068.